GLIBENCLAMIDE TEVA 5 mg, scored tablet 180 tablets
Active ingredients: Glyburide
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet180 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLIBENCLAMIDE TEVA 5 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 180 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Nov 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60026957CIP73875331CIP133400938753318Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GLIBENCLAMIDEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.